The disease often improves with age. The risk-benefit correlation does not support the use of systemic retinoids for the treatment of ulerythema ophryogenes.
Mild keratolytics, such as lactic acid 5%, urea 5%, or salicylic acid 2-5%, may be interchanged with cold creams, while low-potency corticosteroids may also be applied for short periods. Topical retinoid therapy may be worth trying. 
Sun protection creams are recommended when sun exposure is anticipated because frequent exposure to UV radiation exacerbates ulerythema ophryogenes. Local retinoids may not be effective.
Successful treatment with carbon dioxide laser was reported in 2 patients, and the 585-nm pulsed dye lasers seemed efficient  ; however, in general, the treatment is rather unrewarding. Treatment with intense pulsed light may be worth considering.  Keratosis pilaris rubra and keratosis pilaris atrophicans faciei may be treated with good results using pulsed dye laser at 595-nm wavelength. 
No special diet is necessary.
Excessive sunlight should be avoided.
Patients with ulerythema ophryogenes should not be exposed to the sun without UV protection.
Regular checkups are recommended for patients with this condition.
What would you like to print?